Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Trial of Genistein in Men With Circulating Prostate Cancer Cells

NCT01126879 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT01126879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01126879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Trial of Genistein in Men With Circulating Prostate Cancer Cells
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Terminated
Start date
February 3, 2011
Completion date
December 28, 2013
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the prostate, recurrent prostate cancer, stage i prostate cancer, stage ii prostate cancer, stage iii prostate cancer